Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing

Bahrain’s Ministry of Health

MANAMA, Bahrain, Nov. 29, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom of Bahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes. The move is part of the Kingdom's commitment to continue developing therapeutic and diagnostic services in line with latest global medical advancements, benefiting the health of all.

 

The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the National Genome Project, which aims to utilize gene sequencing in adopting effective national health policies and therapeutic and preventative management plans.

 

For her part, the Minister of Health, Dr. Jaleela bint Al-Sayed Jawad Hassan noted that acquiring this device is in line with continuing efforts to keep abreast of latest technological trends in the health field, while further developing the National Genome Centre, which will reflect positively on the various diagnostic and therapeutic services in place for the benefit of the community.

 

Meanwhile, Dr. Gregory Essert, General Manager of Emerging Markets at Illumina, stated, "Through our latest specialized device in genome sequencing, NovaSeqTM X Plus, we can generate more than 20,000 whole genomes per year – 2.5 times our previous capacity, we look forward to contributing to the National Genome Centre's goal in the Kingdom of Bahrain by employing technology to gain a better understanding of diseases and potential genetic risks, thereby developing healthcare plans."

 

Likewise, Mr Abdelrahman Ramadan, the Chief Executive *officer* of Zahrawi Group who's the local representative of Illumina in Bahrain has emphasized, "We believe that the

 

Bahrain National Genome Project, in tandem with Zahrawi Group's vision and mission, symbolizes a significant step towards achieving excellence in genomics research, fostering trust, and making meaningful contributions to the well-being of people in the GCC region and beyond".

 

It is worth mentioning that the National Genome Project was launched in the Kingdom of Bahrain in 2019, and awareness campaigns have been initiated by public health institutions to encourage community participation in the program, with a target of collecting 50,000 samples by 2024.

 

A national delegation of specialists from the National Genome Centre was sent to Harvard University in the United States to undergo specialized training, including the latest methods of genome sequencing, biological data classification, clinical analysis, scientific data analysis, and genetic data management.

 

PR Newswire Asia Ltd.

 

 

PR Newswire
1954年に設立された世界初の米国広報通信社です。配信ネットワークで全世界をカバーしています。Cision Ltd.の子会社として、Cisionクラウドベースコミュニケーション製品、世界最大のマルチチャネル、多文化コンテンツ普及ネットワークと包括的なワークフローツールおよびプラットフォームを組み合わせることで、様々な組織のストーリーを支えています。www.prnasia.com

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

プレスリリース添付画像

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中